Sort
39,280 grants matching “leukemia”
Project 1: Biomarkers of Chemical Exposure and Leukemia Risk
$304,584Martyn T Smith · University Of California Berkeley · P42 · FY2015 · ES
Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients
$304,515Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA
Molecular Targeting of MLL and Associated Factors
$304,513Michael L Cleary · Stanford University · R01 · FY2012 · CA
Novel Strategies for Hematopoietic Transplantation for Chronic Myeloid Leukemia
$304,509Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
Studies of BCR-ABL leukemogenesis in mice
$304,498Richard A. Van Etten · Tufts Medical Center · R01 · FY2012 · CA
Retrovirus Assembly and Maturation
$304,497Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Neuroimaging to Assess the Effects of Therapy in Children with Acute Lymphoblasti
$304,481Bruce T. Shiramizu · University Of Hawaii At Manoa · R21 · FY2010 · CA
Neuroimaging to Assess the Effects of Therapy in Children with Acute Lymphoblasti
$304,481Bruce T. Shiramizu · University Of Hawaii At Manoa · R21 · FY2009 · CA
Core C: Animal Models
$304,455Stefan Niewiesk · Ohio State University · P01 · FY2015 · CA
Effects of Polymorphism on Levels of KIR Expression
$304,449Peter R Parham · University Of California, San Francisco · P01 · FY2009 · AI
Notch Mediated Intercellular Communication and Cell Cycle Regulation
$304,445Wu-Min Deng · Florida State University · R01 · FY2017 · GM
Resistance of CML Stem Cells to Imatinib (Gleevec)
$304,444Ravi Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2009 · CA
Nonsense codon activation of endonuclease-mediated mRNA decay
$304,425Daniel R. Schoenberg · Ohio State University · R01 · FY2010 · GM
NMR Studies of HIV-1 Proteins
$304,369Michael F. Summers · University Of Maryland Baltimore County · R37 · FY2008 · AI
Recombinant AAV Gene Therapy Vector Recombination, Integration, and Genotoxicity
$304,340Douglas M McCarty · Research Inst Nationwide Children'S Hosp · R01 · FY2009 · AI
Recombinant AAV Gene Therapy Vector Recombination, Integration, and Genotoxicity
$304,340Douglas M McCarty · Research Inst Nationwide Children'S Hosp · R01 · FY2008 · AI
Roles of SIRT1 in normal hematopoietic and leukemic stem cells
$304,328Wenyong Chen · Beckman Research Institute/City Of Hope · R01 · FY2014 · CA
IL7 AND IL7R TARGETED THERAPEUTIC AGENTS FOR LEUKEMIA
$304,293Boston Medical Center · R01 · FY2000 · CA
Hematopoietic stem cell gene therapy for sickle cell disease
$304,279Derek A Persons · St. Jude Children'S Research Hospital · U54 · FY2009 · HL
Molecular Targeting of MLL and Associated Factors
$304,221Michael L Cleary · Stanford University · R01 · FY2011 · CA
Signal Transduction Therapy--Clinical
$304,217Elise C. Kohn · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Determinants of Relapse Risk After BMT for ALL
$304,189Stephan A Grupp · Children'S Hosp Of Philadelphia · R01 · FY2007 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$304,169Johns Hopkins University · U10 · FY2001 · CA
Trajectory and Architecture of Microenvironment-Mediated Resistance in AMLÂ
$304,153Anupriya Agarwal · Oregon Health & Science University · U54 · FY2023 · CA
Trajectory and Architecture of Microenvironment-Mediated Resistance in AMLÂ
$304,153Anupriya Agarwal · Oregon Health & Science University · U54 · FY2025 · CA